Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2012
04/05/2012WO2012044193A1 A method of extraction and purification of nucleic acids from liquid medium and a vessel of plastic for nucleic acids sorption from liquid medium
04/05/2012WO2012044171A1 Regulation of translation of expressed genes
04/05/2012WO2012043826A1 Method for transformation of stramenopile
04/05/2012WO2012043814A1 Method for differentiating human-derived pluripotent stem cells
04/05/2012WO2012043808A1 Heat shock protein expression inducer
04/05/2012WO2012043755A1 Cis-acting element and utilization thereof
04/05/2012WO2012043710A1 GROWTH-REGULATED VIRAL VECTOR CONTAINING THE Aurora KINASE PROMOTER
04/05/2012WO2012043653A1 Novel transaminase showing high activity for glutamic acid, gene encoding same, and method for utilization thereof
04/05/2012WO2012043651A1 Production method for myeloid blood cells
04/05/2012WO2012043634A1 Antibody against human prostaglandin e2 receptor ep4
04/05/2012WO2012043633A1 Inhibitor of expression of dominantly mutated gene
04/05/2012WO2012043622A1 Novel aminotransferase and gene encoding same, and use of the aminotransferase and the gene
04/05/2012WO2012043601A1 Amadoriase variant
04/05/2012WO2012043533A1 Antihuman ccr7 antibodies, hybridoma, nucleic acid, vector, cell, medicinal composition, and antibody-immobilized carrier
04/05/2012WO2012043477A1 Linker for unimolecular fret biosensor based on principle of fluorescence resonance energy transfer
04/05/2012WO2012043397A1 Peptide capable of binding to immunoglobulin
04/05/2012WO2012043183A1 Method for synthesizing target nucleic acid in feces
04/05/2012WO2012043028A1 Biopolymer optical analysis device and method
04/05/2012WO2012042684A1 Method for transporting potassium ions from outside to inside of a lipid bilayer
04/05/2012WO2012042486A1 Method for inducing mutations and/or epimutations in plants
04/05/2012WO2012041959A1 Treatment of b-cell lymphoma with microrna
04/05/2012WO2012041913A1 Tobacco with reduced cadmium content
04/05/2012WO2012041899A1 Fusion protein for secretory protein expression
04/05/2012WO2012041857A1 System and method for producing functionally distinct nucleic acid library ends through use of deoxyinosine
04/05/2012WO2012041856A1 Modulation of solanaceae fruit ripening
04/05/2012WO2012041802A1 Means and methods for improved protein interaction screening
04/05/2012WO2012041633A1 A method for making an enriched library
04/05/2012WO2012041503A1 Generation of virosome particles
04/05/2012WO2012041496A1 A gene expression signature for the selection of high energy use efficient plants
04/05/2012WO2012041018A1 ANTI TNF α HUMANIZED ANTIBODY AND FRAGMENT ANTIGEN BINDING (FAB) AND USE THEREOF
04/05/2012WO2012040996A1 Primers and method for detection and identification of esophageal hpv virus
04/05/2012WO2012040851A1 Horsetail silicon transporter genes and uses thereof
04/05/2012WO2012040825A1 Recombinant polypeptides for membrane fusion and uses thereof
04/05/2012WO2012040824A1 Anti-ceacam6 antibodies and uses thereof
04/05/2012WO2012040793A1 Method of cloning nucleic acid
04/05/2012WO2012009667A3 Targeted 2'-o-methylation of telomerase non-coding rna
04/05/2012WO2012008748A9 Mannose 6-phosphate isomerase mutant derived from geobacillus thermodenitrificans, and production method of l-ribose using same
04/05/2012WO2012006577A3 Direct reprogramming of cells to cardiac myocyte fate
04/05/2012WO2012006551A3 Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules
04/05/2012WO2012006440A3 Endothelial cell production by programming
04/05/2012WO2012003279A3 Bioengineered protein pores
04/05/2012WO2011163446A3 Pan-lyssavirus vaccines against rabies
04/05/2012WO2011156795A3 Nucleic acids for multiplex organism detection and methods of use and making the same
04/05/2012WO2011156673A3 Modulation of phosphoenolpyruvate carboxykinase-mitochondrial (pepck-m) expression
04/05/2012WO2011153501A9 Methods for improving inflammatory bowel disease diagnosis
04/05/2012WO2011150117A3 Enhanced disease resistance by introduction of nh3
04/05/2012WO2011150075A3 Compositions and methods for detecting a neoplasia
04/05/2012WO2011150007A3 Treatment of methionine sulfoxide reductase a (msra) related diseases by inhibition of natural antisense transcript to msra
04/05/2012WO2011150005A3 Treatment of atonal homolog 1 (atoh1) related diseases by inhibition of natural antisense transcript to atoh1
04/05/2012WO2011146674A3 Treatment of bcl2-like 11 (bcl2l11) related diseases by inhibition of natural antisense transcript to bcl2l11
04/05/2012WO2011143660A3 Compositions and methods for treating leukemia
04/05/2012WO2011143611A3 Karyotyping assay
04/05/2012WO2011143478A3 Identification of nucleic acids
04/05/2012WO2011143317A3 Methods for the regulation of cellular metabolism through the modulation of sirt3 activity
04/05/2012WO2011142545A3 Method for inhibiting the induction of cell death by inhibiting the synthesis or secretion of age-albumin in cells of the mononuclear phagocyte system
04/05/2012WO2011140285A3 Combinations of tgfbeta and cox-2 inhibitors and methods for their therapeutic application
04/05/2012WO2011140237A3 Process for detection of multidrug resistant tuberculosis using real-time pcr and high resolution melt analysis
04/05/2012WO2011139920A3 Methylation-specific competitive allele-specific taqman polymerase chain reaction (cast-pcr)
04/05/2012WO2011139798A3 Modified pyr/pyl receptors activated by orthogonal ligands
04/05/2012WO2011139769A3 Immunogenic compositions and methods for treating neoplasia
04/05/2012WO2011139032A3 Primer composition for amplifying a gene region having diverse variations in a target gene
04/05/2012WO2011135222A3 Use of peptides as transporters intended for the internalization of molecules of interest into target cells
04/05/2012WO2011133947A3 X-str multiplex system
04/05/2012WO2011132940A3 Rtk-bpb specifically binding to rtk
04/05/2012WO2011132939A3 Rtk-bpb specifically binding to rtk
04/05/2012WO2011126768A9 Methods and materials for detecting colorectal cancer and adenoma
04/05/2012WO2011119979A3 Antibodies to muc16 and methods of use thereof
04/05/2012WO2011118982A3 Hpv antibody screening method using fusion polypeptide hpv antigens
04/05/2012WO2011116226A3 Display of antibody fragments on virus-like particles of rna bacteriophages
04/05/2012WO2011111966A3 Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses
04/05/2012WO2011107299A9 Method for the manufacture of recombinant dspa alpha1
04/05/2012WO2011105841A3 Recombinant expression vector for expressing brazzein, and novel multiple mutation brazzein variant having greater sweetness
04/05/2012US20120084890 Regulatory sequences for expressing gene products in plant reproductive tissue
04/05/2012US20120084889 Novel Fatty Acid Elongation Components and Uses Thereof
04/05/2012US20120084885 Promoter, promoter control elements, and combinations, and uses thereof
04/05/2012US20120084884 Stably transformed ferns and related methods
04/05/2012US20120084883 High Oil Content Plants
04/05/2012US20120084882 Nematode-resistant transgenic plants
04/05/2012US20120084881 Drought tolerant plants
04/05/2012US20120084880 Control of gene expression in plants
04/05/2012US20120084878 Soybean Cultivar 2306521658
04/05/2012US20120084877 Soybean Cultivar 2522121658
04/05/2012US20120084876 Soybean Cultivar 2484721658
04/05/2012US20120084875 Soybean Cultivar 2472221658
04/05/2012US20120084874 Soybean Cultivar 2293921658
04/05/2012US20120084873 Sex-determination and methods of specifying same
04/05/2012US20120084872 Methods for producing micrornas
04/05/2012US20120084871 Npc1l1 orthologues
04/05/2012US20120083615 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
04/05/2012US20120083596 Pharmaceutical Composition
04/05/2012US20120083595 RICE BLAST SUSCEPTIBILITY GENE Pi21, RESISTANCE GENE pi21, AND USES THEREOF
04/05/2012US20120083590 Polypeptides having dna polymerase activity
04/05/2012US20120083588 Neutral amino acid transporter and gene thereof
04/05/2012US20120083587 Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (ma)
04/05/2012US20120083520 Ghrelin binding nucleic acids
04/05/2012US20120083442 Myostatin binding agents
04/05/2012US20120083428 Method and Device for Protein Delivery into Cells
04/05/2012US20120083426 Method
04/05/2012US20120083420 Compositions and methods for the treatment of immune related diseases
04/05/2012US20120083418 Method for designing primers for selex method, method for producing the primers, method for producing aptamers, system for designing the primers, and computer program and recording medium for designing the primers